Literature DB >> 11425421

Fake artesunate in southeast Asia.

P Newton, S Proux, M Green, F Smithuis, J Rozendaal, S Prakongpan, K Chotivanich, M Mayxay, S Looareesuwan, J Farrar, F Nosten, N J White.   

Abstract

Artesunate is a key antimalarial drug in the treatment of multidrug-resistant Plasmodium falciparum malaria in southeast Asia. We investigated the distribution of counterfeit artesunate tablets by use of the validated, simple, and inexpensive Fast Red TR dye technique. We also aimed to identify distinguishing characteristics of the fake drugs. Of 104 shop-bought "artesunate" samples from Cambodia, Laos, Myanmar (Burma), Thailand, and Vietnam, 38% did not contain artesunate. Characteristics such as cost and physical appearance of the tablets and packaging reliably predicted authenticity. The illicit trade in counterfeit antimalarials is a great threat to the lives of patients with malaria. The dye test will assist national malaria control authorities in urgently needed campaigns to stop this murderous trade.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11425421     DOI: 10.1016/S0140-6736(00)05085-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  54 in total

1.  Murder by fake drugs.

Authors:  Paul N Newton; Nicholas J White; Jan A Rozendaal; Michael D Green
Journal:  BMJ       Date:  2002-04-06

2.  Challenges and prospects for malaria elimination in the Greater Mekong Subregion.

Authors:  Liwang Cui; Guiyun Yan; Jetsumon Sattabongkot; Bin Chen; Yaming Cao; Qi Fan; Daniel Parker; Jeeraphat Sirichaisinthop; Xin-zhuan Su; Henglin Yang; Zhaoqing Yang; Baomin Wang; Guofa Zhou
Journal:  Acta Trop       Date:  2011-04-14       Impact factor: 3.112

Review 3.  Therapy of falciparum malaria in sub-saharan Africa: from molecule to policy.

Authors:  Peter Winstanley; Stephen Ward; Robert Snow; Alasdair Breckenridge
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

4.  The quality of drugs in private pharmacies in Lao PDR: a repeat study in 1997 and 1999.

Authors:  Lamphone Syhakhang; Cecilia Stålsby Lundborg; Björn Lindgren; Göran Tomson
Journal:  Pharm World Sci       Date:  2004-12

5.  Validation of ELISA for quantitation of artemisinin-based antimalarial drugs.

Authors:  Min Wang; Yongliang Cui; Guofa Zhou; Guiyun Yan; Liwang Cui; Baomin Wang
Journal:  Am J Trop Med Hyg       Date:  2013-09-30       Impact factor: 2.345

Review 6.  Substandard/counterfeit antimicrobial drugs.

Authors:  Theodoros Kelesidis; Matthew E Falagas
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

7.  Classification and Visualization of Physical and Chemical Properties of Falsified Medicines with Handheld Raman Spectroscopy and X-Ray Computed Tomography.

Authors:  Tomoko Kakio; Naoko Yoshida; Susan Macha; Kazunobu Moriguchi; Takashi Hiroshima; Yukihiro Ikeda; Hirohito Tsuboi; Kazuko Kimura
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

8.  Impaired clinical response in a patient with uncomplicated falciparum malaria who received poor-quality and underdosed intramuscular artemether.

Authors:  Valy Keoluangkhot; Michael D Green; Leonard Nyadong; Facundo M Fernández; Mayfong Mayxay; Paul N Newton
Journal:  Am J Trop Med Hyg       Date:  2008-04       Impact factor: 2.345

9.  A stratified random survey of the proportion of poor quality oral artesunate sold at medicine outlets in the Lao PDR - implications for therapeutic failure and drug resistance.

Authors:  Sivong Sengaloundeth; Michael D Green; Facundo M Fernández; Ot Manolin; Khamlieng Phommavong; Vongsavanh Insixiengmay; Christina Y Hampton; Leonard Nyadong; Dallas C Mildenhall; Dana Hostetler; Lamphet Khounsaknalath; Latsamy Vongsack; Samlane Phompida; Viengxay Vanisaveth; Lamphone Syhakhang; Paul N Newton
Journal:  Malar J       Date:  2009-07-28       Impact factor: 2.979

Review 10.  Retail sector distribution chains for malaria treatment in the developing world: a review of the literature.

Authors:  Edith Patouillard; Kara G Hanson; Catherine A Goodman
Journal:  Malar J       Date:  2010-02-11       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.